Comments to FDA: Label Comprehension Studies for Nonprescription Drugs

Share page:
Docket Number:
FDA-2009-D-0181

CHPA and its member companies have an interest and expertise in label comprehension studies and support FDA's efforts to develop guidance for industry on this important topic.

Related Posts

CHPA Statement on Valisure Citizen Petition